Literature DB >> 24200609

[Neurological involvement in Wegener's granulomatosis].

Kunihiko Asakura1, Tatsuro Muto.   

Abstract

Abstract Wegener's granulomatosis is a rare autoimmune disease associated with granulomatous inflammation and anti-neutrophil cytoplasmic antibody (ANCA)-associated small vessel vasculitis. Following the discovery of ANCA, ANCA-associated vasculitis is established as a disease entity of Wegener's granulomatosis, microscopic polyangiitis, and Churg-Strauss syndrome. Clinical and experimental studies have provided evidences that myeloperoxidase (MPO) and proteinase 3 (PR3), which are major antigenic targets for ANCA in neutrophils, are not only disease markers but also involved in the pathogenesis. In addition, recent studies have revealed another potential antigen for ANCA, lysosomal-associated membrane protein-2 (LAMP-2). Though nervous system manifestations of Wegener's granulomatosis are less frequent than classical manifestations in the lungs and kidneys, 20-50% of patients demonstrate neurological involvements. Peripheral nervous system involvement (in generalized Wegener's granulomatosis) is more frequent than central nervous system (CNS) involvement. Multiple mononeuropathy and multiple cranial neuropathy are the most prevalent symptoms. CNS manifestations include cerebrovascular events, pachymeningitis, seizures, and reversible posterior leukoencephalopathy syndrome. Here we discuss the pathogenic mechanism of ANCA and review the literature regarding neurological involvement in Wegener's granulomatosis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24200609

Source DB:  PubMed          Journal:  Brain Nerve        ISSN: 1881-6096


  3 in total

Review 1.  Multiple Sclerosis: Diagnosis and Differential Diagnosis.

Authors:  Sami Ömerhoca; Sinem Yazici Akkaş; Nilüfer Kale İçen
Journal:  Noro Psikiyatr Ars       Date:  2018       Impact factor: 1.339

2.  Facial nerve palsy, headache, peripheral neuropathy and Kaposi's sarcoma in an elderly man.

Authors:  Dimitrios Daoussis; Elisabeth Chroni; Athanassios C Tsamandas; Andrew P Andonopoulos
Journal:  World J Clin Cases       Date:  2014-06-16       Impact factor: 1.337

3.  The MRZ reaction helps to distinguish rheumatologic disorders with central nervous involvement from multiple sclerosis.

Authors:  Tilman Hottenrott; Rick Dersch; Benjamin Berger; Dominique Endres; Daniela Huzly; Jens Thiel; Sebastian Rauer; Oliver Stich; Ulrich Salzer; Nils Venhoff
Journal:  BMC Neurol       Date:  2018-01-31       Impact factor: 2.474

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.